Tremelimumab (anti-CTLA-4)
Catalogue Number: A2021-SEL
| Manufacturer: | Selleck Chemicals |
| Type: | Recombinant Monoclonal |
| Shipping Condition: | Dry Ice |
| Unit(s): | 5 mg, 1 mg, 25 x 1 mg |
Description
Description: Tremelimumab (Ticilimumab, CP-675,206) is a fully human monoclonal antibody that binds to cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) on the surface of activated T lymphocytes.
Additional Text
CAS Number
745013-59-6
A2021 MSDS
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations